Pravastatin (drug) for head and neck neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 Apr 2025: Trial registered, NCT06912763
  2. 8 Aug 2025: Trial started, NCT06912763

The trials

NCT06912763: Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

State
Under way
Phase
Phase 2
People
250 planned
Started
8 Aug 2025
Primary completion
31 Jul 2030
Arms
Treatment with Pravastatin QD
Results
None posted
  1. 6 Apr 2025: Trial registered
  2. 8 Aug 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.